Oncologix Tech, Inc.
OCLGOTCFinancial Services● Active
$0.00
+$0.00(+0.00%)
Market Cap$73662
P/E Ratio—
52W High$0.001
52W Low$0.0001
Oncologix Tech, Inc. (OCLG) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
OCLG · earnings · updated Jun 9, 2026
Latest Earnings
Q3 FY2015Report Date: Jul 21, 2015EPS Actual
-$0.00
Revenue
$0.00B
Fiscal Period
Q3 FY2015
FY ends December
Report Date
Jul 21, 2015
After Market Close
OCLG reports quarterly as a OTC-listed Shell Companies company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q3 FY2015 | Jul 21, 2015 | — | -$0.00 | — | $0.00B | — | — |
| — Q2 FY2015 | Apr 14, 2015 | — | -$0.00 | — | $0.00B | — | — |
| — Q1 FY2015 | Jan 16, 2015 | — | -$0.00 | — | $0.00B | — | — |
| — Q3 FY2014 | Aug 31, 2014 | — | -$0.00 | — | $0.00B | — | — |
| — Q3 FY2014 | Jul 15, 2014 | — | -$0.00 | — | $0.00B | — | — |
| — Q2 FY2014 | Apr 21, 2014 | — | -$0.01 | — | $0.00B | — | — |
| — Q1 FY2014 | Jan 16, 2014 | — | -$0.00 | — | $0.00B | — | — |
| — Q3 FY2013 | Aug 31, 2013 | — | -$0.00 | — | $0.00B | — | — |
Q3 FY2015
Jul 21, 2015
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2015
Apr 14, 2015
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2015
Jan 16, 2015
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2014
Aug 31, 2014
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2014
Jul 15, 2014
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2014
Apr 21, 2014
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2014
Jan 16, 2014
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2013
Aug 31, 2013
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2024 | $1.54 | $1.54 | $1.54 | 1 |
| Q2 FY2024 | $1.34 | $1.34 | $1.34 | 1 |
| Q1 FY2024 | $1.58 | $1.58 | $1.58 | 1 |
| Q4 FY2023 | $2.09 | $2.09 | $2.09 | 1 |
| Q3 FY2023 | $1.39 | $1.39 | $1.39 | 1 |
| Q2 FY2023 | $1.19 | $1.19 | $1.19 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2024 | $0.0B | $0.0B | $0.0B | 0 |
| Q2 FY2024 | $0.0B | $0.0B | $0.0B | 0 |
| Q1 FY2024 | $0.0B | $0.0B | $0.0B | 0 |
| Q4 FY2023 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2023 | $0.0B | $0.0B | $0.0B | 0 |
| Q2 FY2023 | $0.0B | $0.0B | $0.0B | 0 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q3 FY2015 | Jul 21, 2015 | — | $0.00 | $0.00 | -9.52% |
| — Q2 FY2015 | Apr 14, 2015 | — | $0.00 | $0.01 | +14.89% |
| — Q1 FY2015 | Jan 16, 2015 | — | $0.00 | $0.01 | +35.71% |
| — Q3 FY2014 | Aug 31, 2014 | — | $0.01 | $0.01 | -10.00% |
| — Q3 FY2014 | Jul 15, 2014 | — | $0.01 | $0.01 | +10.00% |
| — Q2 FY2014 | Apr 21, 2014 | — | $0.01 | $0.01 | +17.33% |
| — Q1 FY2014 | Jan 16, 2014 | — | $0.02 | $0.03 | +42.11% |
| — Q3 FY2013 | Aug 31, 2013 | — | $0.01 | $0.01 | -34.86% |
Q3 FY2015-9.52%
Report Date
Jul 21, 2015
EPS Beat/Miss
—
Price Before
$0.00
Price After
$0.00
Q2 FY2015+14.89%
Report Date
Apr 14, 2015
EPS Beat/Miss
—
Price Before
$0.00
Price After
$0.01
Q1 FY2015+35.71%
Report Date
Jan 16, 2015
EPS Beat/Miss
—
Price Before
$0.00
Price After
$0.01
Q3 FY2014-10.00%
Report Date
Aug 31, 2014
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q3 FY2014+10.00%
Report Date
Jul 15, 2014
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q2 FY2014+17.33%
Report Date
Apr 21, 2014
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q1 FY2014+42.11%
Report Date
Jan 16, 2014
EPS Beat/Miss
—
Price Before
$0.02
Price After
$0.03
Q3 FY2013-34.86%
Report Date
Aug 31, 2013
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Beat Rate0 / 8 quarters
Largest Move+42.11% (Q1 FY2014)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: OCLG ends December
Oncologix Tech, Inc. (OCLG) most recently reported earnings on July 21, 2015 for Q3 FY2015, posting EPS of $-0.00 (in line with the analyst consensus of —). The next OCLG earnings date is expected around September 1, 2026.
Each quarter, investors track OCLG earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. OCLG revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
OCLG's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
OCLG earnings · 4 questionsOncologix Tech, Inc.'s next earnings report is expected around September 1, 2026. OCLG typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; OCLG historically reports after market close (AMC).
OCLG earnings datewhen is OCLG earningsOCLG next earnings datewhen does OCLG report earningsOCLG earnings calendar
▸ Source: FMP · Oncologix Tech, Inc. SEC filings · US GAAP · Oncologix Tech, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026